Literature DB >> 14750954

Src-dependent phosphorylation of the EGF receptor Tyr-845 mediates Stat-p21waf1 pathway in A431 cells.

Ken-ichi Sato1, Tomomi Nagao, Tetsushi Iwasaki, Yusuke Nishihira, Yasuo Fukami.   

Abstract

BACKGROUND: Cell surface receptor for the epidermal growth factor (EGFR) and cytoplasmic tyrosine kinase c-Src co-operate in several cellular functions such as proliferation and apoptosis. Our previous studies have shown that ectopic expression of the adaptor protein p52shc or p66shc, but not p46shc, and EGF stimulation lead to the activation of c-Src that is accompanied by phosphorylation of signal transducers and activators of transcription (Stat) in A431 cells.
RESULTS: Here, we show that by using A431 cells as a model system, expression of p52shc, or cell stimulation with EGF or H2O2 leads to phosphorylation of EGFR on Tyr 845 that is located to the activation segment of the catalytic domain. The phosphorylation of Tyr 845 can be inhibited by PP2, but not by AG1478, and is associated with Src activation and Stat 3/5 phosphorylation, but not with MAP (mitogen-activated protein) kinase phosphorylation. Phosphorylation of Stat 3/5 in response to p52shc expression, EGF or H2O2 could also be inhibited by introduction into cells of phospho-Tyr 845-specific antibody or by expression of dominant-negative version of c-Src. Co-incubation of purified c-Src and EGFR results in phosphorylation of Tyr 845 in vitro, indicating that c-Src can directly phosphorylate EGFR on Tyr 845.
CONCLUSION: These results indicate that multiple signals for c-Src activation can promote Stat 3/5 phosphorylations through Src-dependent phosphorylation of EGFR on Tyr 845.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14750954     DOI: 10.1046/j.1356-9597.2003.00691.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  28 in total

Review 1.  Targeting antibodies to the cytoplasm.

Authors:  Andrea L J Marschall; André Frenzel; Thomas Schirrmann; Manuela Schüngel; Stefan Dübel
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

2.  Ligand-independent phosphorylation of Y869 (Y845) links mutant EGFR signaling to stat-mediated gene expression.

Authors:  Seungchan Yang; Kyungho Park; James Turkson; Carlos L Arteaga
Journal:  Exp Cell Res       Date:  2007-09-08       Impact factor: 3.905

3.  Regulation of lysophosphatidic acid-induced epidermal growth factor receptor transactivation and interleukin-8 secretion in human bronchial epithelial cells by protein kinase Cdelta, Lyn kinase, and matrix metalloproteinases.

Authors:  Yutong Zhao; Donghong He; Bahman Saatian; Tonya Watkins; Ernst Wm Spannhake; Nigel J Pyne; Viswanathan Natarajan
Journal:  J Biol Chem       Date:  2006-05-10       Impact factor: 5.157

4.  Sulfiredoxin Promotes Colorectal Cancer Cell Invasion and Metastasis through a Novel Mechanism of Enhancing EGFR Signaling.

Authors:  Hong Jiang; Lisha Wu; Jing Chen; Murli Mishra; Hedy A Chawsheen; Haining Zhu; Qiou Wei
Journal:  Mol Cancer Res       Date:  2015-08-19       Impact factor: 5.852

5.  C-X-C chemokine receptor 7: a functionally associated molecular marker for bladder cancer.

Authors:  Travis J Yates; Judith Knapp; Miguel Gosalbez; Soum D Lokeshwar; Christopher S Gomez; Anaid Benitez; Obi O Ekwenna; Ezekiel E Young; Murugesan Manoharan; Vinata B Lokeshwar
Journal:  Cancer       Date:  2012-06-26       Impact factor: 6.860

6.  Src family kinase inhibitor PP2 efficiently inhibits cervical cancer cell proliferation through down-regulating phospho-Src-Y416 and phospho-EGFR-Y1173.

Authors:  Lu Kong; Zhihong Deng; Haiying Shen; Yuxiang Zhang
Journal:  Mol Cell Biochem       Date:  2010-11-04       Impact factor: 3.396

7.  EGFR activation attenuates the mechanical threshold for integrin tension and focal adhesion formation.

Authors:  Tejeshwar C Rao; Victor Pui-Yan Ma; Aaron Blanchard; Tara M Urner; Shreya Grandhi; Khalid Salaita; Alexa L Mattheyses
Journal:  J Cell Sci       Date:  2020-07-10       Impact factor: 5.285

8.  Protein C receptor stimulates multiple signaling pathways in breast cancer cells.

Authors:  Daisong Wang; Chunye Liu; Jingqiang Wang; Yingying Jia; Xin Hu; Hai Jiang; Zhi-Ming Shao; Yi Arial Zeng
Journal:  J Biol Chem       Date:  2017-12-07       Impact factor: 5.157

9.  Therapeutic IMC-C225 antibody inhibits breast cancer cell invasiveness via Vav2-dependent activation of RhoA GTPase.

Authors:  Poonam R Molli; Liana Adam; Rakesh Kumar
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

10.  The combination of epidermal growth factor receptor inhibitors with gemcitabine and radiation in pancreatic cancer.

Authors:  Meredith A Morgan; Leslie A Parsels; Laura E Kollar; Daniel P Normolle; Jonathan Maybaum; Theodore S Lawrence
Journal:  Clin Cancer Res       Date:  2008-08-15       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.